- cafead Nov 12, 2016 at 06:37: PM
From CP's front page news today, an article from Investopedia:
Sanofi Took $100M Hit on MannKind Deal
Sanofi has settled a licensing termination agreement with MannKind to stop marketing the inhaled insulin Afrezza.
Among the interesting facts in the article, apparently around $2 million worth of product is still stored with wholesalers which is yet to be sold, and those revenues are recorded as deferred.
Sanofi Took $100M Hit on MannKind Deal
Sanofi has settled a licensing termination agreement with MannKind to stop marketing the inhaled insulin Afrezza.
Among the interesting facts in the article, apparently around $2 million worth of product is still stored with wholesalers which is yet to be sold, and those revenues are recorded as deferred.